NCT00004049View on ClinicalTrials.gov

SR-45023A in Treating Patients With Locally Advanced or Metastatic Solid Tumors

PHASE1CompletedINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

April 30, 1999

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG

apomine

Trial Locations (1)

78245-3217

Institute for Drug Development, San Antonio

All Listed Sponsors

lead

Genzyme, a Sanofi Company

INDUSTRY